Further Placing

Seeing Machines Limited 25 September 2007 25 September 2007 Seeing Machines Limited ('Seeing Machines' or the 'Company') Further Placing Further to yesterday's announcement (24 September 2007) regarding a fund raising, Seeing Machines (AIM: SEE), a leading developer of advanced computer based imaging software systems, is pleased to announce the conclusion today of the supplementary fund raising of £112,869.85 before expenses via the issue of 4,514,794 new Ordinary Shares at 2.5p per share through a placing (the 'Further Placing') to directors and staff of the Company, conditional on shareholder approval. The Further Placing is in addition to the placing announced yesterday of up to 51,485,206 new ordinary shares at 2.5 pence per share (the 'Placing') and brings the potential total of the funds raised in the combined placings to £1.4 million before expenses, via the issue of up to 56,000,000 new ordinary shares at the 2.5p per share placing price. Commenting on the two placings Fulton Muir, Chairman of Seeing Machines said ' The funds raised in this placing provide a solid base of working capital for the company to accelerate the commercialization of our new product lines, including the Driver State Sensor, faceAPI and the upcoming TrueField Analyzer. These efforts comprise a central element of our strategy to transition the Company from its history of development and net cash burn to self sustainability and to use that as a platform to realize our significant commercial potential. The placing has been fully subscribed, and at a placing price of 2.5 pence per share it compares favourably with the prevailing mid-market price of 2.375 pence per share.' As announced yesterday a circular containing a Notice of Meeting convening a General Meeting of the Company in Acton, ACT, Australia on 26 October 2007 for the purpose of seeking the required shareholder approval for the two placings has been posted to shareholders and is available from the investor pages of the Company's web site www.seeingmachines.com. A presentation by the Company provided to potential investors in the Placing is also available from those same pages on the Company's website. --- ENDS --- Enquiries: Seeing Machines Limited Insinger de Beaufort Parkgreen Communications Nick Cerneaz, CEO Peter Ward, Chris Ben Knowles, Erica Caldwell Nelson +61 (0) 2 6125 6501 +44 (0) 20 7190 7015 +44 (0) 20 7851 7480 www.seeingmachines.com Notes to editors: About Seeing Machines Seeing Machines is an award winning Technology Company which focuses on vision based human machine interfaces. Formed in 2000 in Canberra, Australia, Seeing Machines' purpose is to commercialise its computer-vision across a range of industries and applications. Seeing Machines deliver advanced computer vision solutions for researches and developers in human factors, transportation safety, computer human interaction, robotics, medical research and psychology. The flagship product faceLAB(R) provides an automated and contact-free gaze and head tracking technology, it solves the problem of observing human behaviour naturally, non-intrusively and with a high degree of accuracy and usability. Building on these unique face tracking and pupil measurement and monitoring capabilities, the TrueField Analyzer(R) is new medical device to assist clinicians detect and manage eye diseases such as glaucoma. The TrueField Analyzer(R) offers a new objective method to help doctors diagnose and manage a range of eye diseases including glaucoma, age related macular degeneration and diabetic retinopathy. Glaucoma affects about 2-3% of the population over 40 years of age and is a leading source of blindness. Unlike most other devices available to the clinician the TrueField Analyzer is a completely objective test and it is quick and easy for patients and technicians alike. The device measures both eyes concurrently and due to the reliability that arises from the objective nature of the test, it has the potential to become a new standard in the measurement of visual field defects and thus in the diagnosis and management of disease such as glaucoma. More generally Seeing Machines' computer vision systems are able to measure the orientation and position of a human head, estimate eye-gaze direction, detect eye blinks and track other facial features. This functionality is achieved entirely though visual means, using video cameras connected to advanced image processing software, with no attachments required on the subject. Products such as faceLAB(R) are designed to allow human factors researchers and designers to assess the interaction of an operator in an environment and this finds application in designing operator environments, such as cockpits for cars, trucks, trains, and aeroplanes for instance, and other industrial design applications, as well as medical and psychological research situations. The technology has been developed into the Driver State Sensor (DSS2) product for application in monitoring vehicle drivers and if it detects drowsiness (fatigue) or that the driver is distracted and their attention has been diverted from the road, alarms are raised to alert the driver to these events. In larger deployments, such as in fleet and mining equipment operations, the data is available in both real-time and off-line modes for fleet management, driver training and awareness programs The systems work in real-time, enabling the behaviour of subjects to be tracked in real-time. This technology is paving the way in promoting safer driving conditions and works to enhance the driving experience and to eliminate accidents caused through driver drowsiness or distraction. There are many different sectors that can benefit from this revolutionary software, for which it has been developed, including: automotive; academic research; medicine/healthcare; defence; autostereoscopy (next generation displays); sport; and games. This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings